Medical Imaging
•58 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (58)
%
| Company | Market Cap | Price |
|---|---|---|
|
Medical imaging capabilities embedded in the surgical platforms for visualization and guidance.
|
$153.97B |
$429.59
-3.26%
|
|
Medical Imaging relates to digital pathology imaging and imaging-based diagnostic workflows mentioned (AI-assisted pathology).
|
$144.89B |
$202.46
-1.20%
|
|
Provides medical imaging-related hardware/software and imaging planning tools (e.g., TIVUS imaging, FARAVIEW workflow).
|
$141.15B |
$95.41
-1.94%
|
|
Medical Imaging - visualization/imaging systems used to plan and guide surgical procedures (e.g., visualization platforms like Mako planning imaging).
|
$139.34B |
$364.60
-1.54%
|
|
Verathon and related medical devices involve medical imaging capabilities used in clinical settings.
|
$54.73B |
$509.00
-2.25%
|
|
GE HealthCare manufactures and sells Medical Imaging devices (CT, MR, ultrasound) as core product lines.
|
$32.51B |
$71.01
-4.05%
|
|
Philips' primary product line includes medical imaging hardware and imaging modalities (MRI, CT, ultrasound) used for diagnostics.
|
$26.88B |
$27.35
|
|
Labcorp leverages medical imaging capabilities (digital pathology) and imaging software internally to support diagnostics.
|
$23.26B |
$277.88
-0.11%
|
|
3D Mammography breast imaging systems and related medical imaging capabilities are core product offerings.
|
$14.78B |
$67.92
+0.94%
|
|
Imaging equipment/software used in medical diagnostics and research workflows.
|
$9.91B |
$84.06
+0.79%
|
|
The iTero imaging and dental workflow capabilities place Align in Medical Imaging as a broader category.
|
$9.12B |
$125.79
-2.26%
|
|
Medical imaging systems and intraoperative navigation/imaging platforms (Excelsius3D, imaging workflows).
|
$7.66B |
$56.57
-5.32%
|
|
Medical imaging-related hardware/software capabilities (radiation-based imaging) are part of Mirion's offerings.
|
$5.36B |
$23.12
-1.53%
|
|
Bruker's imaging instruments contribute to medical imaging capabilities used in research and diagnostics.
|
$5.35B |
$35.28
-2.54%
|
|
RadNet's core business is outpatient diagnostic imaging services across MRI, CT, PET, mammography, and ultrasound, i.e., medical imaging services.
|
$5.30B |
$70.60
-3.30%
|
|
Lantheus markets imaging agents used in PET and ultrasound (e.g., PYLARIFY and DEFINITY), a core medical imaging product line.
|
$3.68B |
$53.23
+2.54%
|
|
Illuccix/Gozellix represent radiopharmaceutical imaging agents used for PET/diagnostic imaging, aligning with Medical Imaging.
|
$3.35B |
$10.00
|
|
CBCT imaging platform and related medical imaging hardware/software align with Medical Imaging.
|
$3.23B |
$19.06
-4.94%
|
|
Digital pathology imaging/software component of their diagnostic workflow.
|
$2.73B |
$34.80
-0.66%
|
|
Scientific segment serves healthcare applications that can involve medical imaging-related equipment and systems.
|
$2.62B |
$217.17
-1.72%
|
|
Produces imaging technology and equipment (e.g., 3D dental scanners) used in diagnostics and treatment planning.
|
$2.49B |
$12.50
+2.21%
|
|
The system uses ultrasound imaging as part of its medical imaging capability, fitting Medical Imaging.
|
$2.17B |
$39.15
+1.77%
|
|
Ardent operates hospitals and clinics that deliver medical imaging services (MRI, CT, etc.) as part of patient care.
|
$2.01B |
$14.05
-2.57%
|
|
The EOS imaging system and related imaging hardware/software are major Medical Imaging products.
|
$1.92B |
$13.14
-4.58%
|
|
Includes medical imaging capabilities and visualization components used intraoperatively.
|
$1.35B |
$6.95
-7.09%
|
|
Imaging-guided navigation and MRI-related imaging capabilities integral to the system.
|
$730.80M |
$26.11
-10.61%
|
|
Core ultrasound hardware (Ultrasound-on-Chip) and imaging software constitute Butterfly's primary medical-imaging product line.
|
$563.82M |
$2.28
-10.59%
|
|
Navigation and imaging-enabled surgical technology (e.g., 7D FLASH navigation system).
|
$556.37M |
$14.20
+1.50%
|
|
Operates in the medical imaging space (diagnostic imaging software/hardware).
|
$536.62M |
$2.17
+15.43%
|
|
Core to medical imaging applications (CT, X-ray) as imaging systems; Varex supplies imaging components used in Medical Imaging devices.
|
$500.49M |
$12.06
+1.09%
|
|
Medical Imaging tag corresponds to Materialise's Mimics medical imaging software used for planning and analysis.
|
$342.00M |
$5.79
-6.61%
|
|
Nanox ARC/X are medical imaging systems, a core product line in the company's business.
|
$228.24M |
$3.90
-5.80%
|
|
Accuray's CyberKnife and TomoTherapy/Radixact platforms incorporate integrated medical imaging for treatment planning and guidance.
|
$184.39M |
$1.72
-3.91%
|
|
PEDD deployments occur in interventional settings with imaging guidance; relevant to Medical Imaging category.
|
$163.46M |
$4.32
-2.26%
|
|
Medical Imaging reflects CT imaging hardware produced via Healthcare asset stream (CT tubes, imaging equipment).
|
$163.04M |
$11.25
-2.43%
|
|
Profound's flagship TULSA-PRO system uses MRI for image-guided therapy, placing medical imaging at the core of its product.
|
$144.76M |
$5.87
-10.79%
|
|
Contains medical imaging capabilities and AI-guided imaging components within the device.
|
$140.21M |
$11.89
-1.25%
|
|
Direct product: portable MRI hardware and accompanying imaging software, i.e., medical imaging devices.
|
$136.22M |
$1.75
-13.79%
|
|
Product is used for medical imaging in radiology (breast health screening) and is FDA-cleared as a software-based medical device.
|
$105.91M |
$3.87
|
|
The core business centers on medical imaging hardware and imaging systems (MRI), aligning with Medical Imaging.
|
$102.87M |
$15.62
-0.27%
|
|
The system is image-guided (integration with MRI, PSMA PET, ExactVu, etc.), aligning with the medical imaging category.
|
$77.07M |
$2.07
-5.91%
|
|
LungTraX-based CT analysis and imaging data underpin the company’s medical imaging and diagnostic workflow offerings.
|
$63.61M |
$1.58
-7.06%
|
|
The system relies on medical imaging technology, aligning with the medical imaging equipment category.
|
$57.42M |
$2.23
-8.79%
|
|
Core product is a medical imaging-enabled superficial radiation therapy system (SRT-100 Vision) used for skin cancers and related conditions, relying on imaging for treatment planning.
|
$53.94M |
$3.28
-3.81%
|
|
Medical imaging / visualization capabilities included in the system.
|
$34.64M |
$5.84
-10.43%
|
|
Endoscopes and imaging systems fall under medical imaging equipment and solutions.
|
$33.16M |
$4.33
|
|
Acquisition of Bethesda Medical expands diagnostic imaging within BMGL's healthcare ecosystem.
|
$30.27M |
$1.64
+1.86%
|
|
Medical Imaging is a key market segment referenced in Nortech's customer mix.
|
$24.85M |
$9.00
-0.86%
|
|
LuViva functions as a medical imaging device using light-based biophotonics for cervical assessment.
|
$22.48M |
$0.28
+16.67%
|
|
Femasys' offerings include imaging-based diagnostics and ultrasound-guided confirmation tools, aligning with Medical Imaging category.
|
$16.68M |
$0.61
-8.12%
|
|
AMS uses imaging modalities as part of treatment planning and delivery in radiation therapy.
|
$14.84M |
$2.30
-4.56%
|
|
The C-Scan system includes medical imaging capabilities used for detecting polyps, aligning with medical imaging equipment.
|
$10.77M |
$1.84
-8.00%
|
|
MHUA lists medical imaging consumables (e.g., disposable X-ray films) as part of its product portfolio, aligning with Medical Imaging.
|
$10.18M |
$0.39
-6.47%
|
|
Software relates to medical imaging/planning workflows used in radiotherapy, aligning with Medical Imaging software.
|
$10.15M |
$0.70
-1.14%
|
|
Endoscopic imaging initiatives (e.g., Duke LOI) map to Medical Imaging as a core technology area.
|
$8.61M |
$0.49
-13.83%
|
|
Medical Imaging: imaging hardware/software components used in patient monitoring devices.
|
$3.15M |
$0.02
+33.36%
|
|
VIVO’s 3D mapping/imagery aspect aligns with Medical Imaging as a related product category.
|
$1.60M |
$2.76
-2.82%
|
|
Provides medical imaging-related devices and QA tooling to imaging modalities (SPECT/PET).
|
$518499 |
$0.05
-7.75%
|
Loading industry metrics...
Loading comparison data...
